Ki-1 anaplastic large-cell lymphoma in the differential diagnosis of unknown primary cancer

Cancer Investigation

Volumn 16, Issue 5, 1998, Pages 309-313

  Lokich, Jacob ^a   Sherburne, Bradford ^b  

^a Cancer Center of Boston   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; CANCER; CANCER SURVIVAL; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LABORATORY DIAGNOSIS; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; TREATMENT PLANNING; UNDIFFERENTIATED CARCINOMA;

EID: 0031813570     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809084649     Document Type: Article

References (19)

1. Sandlund JT, Pui CH, Roberts WM, et al: Clinicopathologic features and treatment outcome of children with large-cell lymphomas and the t(2;5) (p23;q35). Blood 84:2467-2471, 1994.
2. Sandlund JT, Pui CH, Santana VM, et al: Clinical features and treatment outcome for children with CD30 + large-cell non-Hodgkin's lymphoma. J Clin Oncol 12:895-898, 1994.
3. Reiter A, Schrappe M, Tiemann M, et al: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12(5):899-908, 1994.
4. Murphy SB: Pediatric lymphomas: Recent advances and commentary on Ki-1 positive anaplastic large cell lymphomas of childhood (Review). Annals of Oncology 5(Suppl 1):31-33, 1994.
5. Camisa C, Helm TN, Sexton C, Tuthill R: Ki-1 positive anaplastic large cell lymphoma can mimic benign dermatosis. J Am Acad Dermatol 29(5 Pt 1):696-700, 1993.
6. von den Driesch P, Bivolarevic I, Peters KP, Hornstein OP: Cutaneous pleomorphic large cell lymphoma. Cutis 50:294-298, 1992.
7. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361-1392, 1994.
8. Delsol G, Al Satti T, Gatter KC, et al: Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin 2 receptor by anaplastic larger cell lymphomas: Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130:59-70, 1988.
9. Arber DA, Weiss LM: CD43: A review. Appl Immunohistochem 1:88-96, 1993.
10. Pileri S, Falini B, Delsol G, et al: Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymophoma CD30+/Ki1 +) with a high content of reactive histiocytes. Histopathology 16:383-391, 1990.
11. Kinney M, Collins RD, Greer J, et al: A small-cell predominant variant of primary Ki-1 (CD 30) + T-cell lymphoma. Am J Surg Pathol 17:859-868, 1993.
12. Lamant L, Meggetto F, Al Satti T, et al: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Blood 87:284-291, 1996.
13. Shiota M, Fujimoto J, Takenaga M, et al: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648-3652, 1994.
14. Chott A, Kaserer K, Augustin I, et al: Ki-1 Positive large cell lymphoma: a clinicopathologic study of 41 cases. Am J Surg Pathol 14:439-448, 1990.
15. Penny RJ, Blaustein JC, Longtine JA, Pinkus GS: Ki-1 Positive large cell lymphomas, a heterogenous group of neoplasms. Cancer 68:362-373, 1991.
16. Greer JP, Kinney MC, Collins RD, et al: Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J Clin Oncol 9:539-547, 1991.
17. Shulman LN, Frisard B, Antin JH, et al: Primary Ki-1 anaplastic large cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol 11:937-942, 1993.
18. de Campos ES, Menasce LP, Redford JA, et al: Metastatic carcinoma of uncertain primary site (CUPS): a review of 57 cases treated with VAC or VAC/PE at the Christie Hospital. Br J Cancer 63(Suppl 13):10, 1991.
19. Pabst T, Ludwig C: CA 125: A tumor marker in non Hodgkin's lymphoma? J Clin Oncol 13:1827-1828, 1995.